- MIC determination (NCCLS standard procedures and ATCC reference strain)
Bacterial panels include Gram-positive, Gram-negative, and anaerobes.
Fungal panels include yeast, and filamentous fungi
- Cross-resistance studies using panels of strains expressing most known drug resistance mechanisms e.g. efflux, ßlactamase production, etc.
- De novo resistance development studies
- Kill-time studies
- Post-antimicrobial effect (PAE) studies
- Effect of body milieus on activity
- Determination of activity on recently collected clinical isolates using over a 4000 bacterial and fungal clinical isolate collection
- High-throughput screening of activity using the Beckman2000 automated workstation
- Drug-drug interaction studies
Microbiology
in vivo Efficacy studies (1 compound per week)
- Thigh Infection (S. aureus)
- Systemic acute S. aureus infection model
- Systemic acute E. coli infection (IP/IV) model
- Lung S. pneumoniae infection model
- Systemic acute C. albicans infection model
- Lung A. fumigatus infection model (Immuncompromized)
- Systemic A. fumigatus infection model
- Systemic C. glabrata infection model (Immuncompromized)